iTeos Therapeutics, Inc. announced the promotion of Yvonne McGrath, Ph.D., to chief scientific officer.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
17.68 USD | +0.80% | -2.05% | +61.46% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+61.46% | 66Cr | |
+12.30% | 12TCr | |
+12.15% | 11TCr | |
-8.14% | 2.34TCr | |
-1.69% | 2.18TCr | |
-10.60% | 1.81TCr | |
-41.25% | 1.67TCr | |
-15.33% | 1.6TCr | |
+5.80% | 1.4TCr | |
+28.03% | 1.17TCr |
- Stock Market
- Equities
- ITOS Stock
- News iTeos Therapeutics, Inc.
- ITeos Therapeutics, Inc. Promotes Yvonne McGrath, Ph.D. to Chief Scientific Officer